Novel immunodeficiency caused by homozygous mutation in solute carrier family 19 member 1, which encodes the reduced folate carrier

Affiliations

• ¹ Division of Immunology and Allergy, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
• ² Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
• ³ Pediatric Bone Marrow Transplantation Unit, Istinye University Faculty of Medicine, Medical Park Antalya Hospital, Antalya, Turkey.
• ⁴ Canadian Centre for Primary Immunodeficiency and Jeffrey Modell Research Laboratory for the Diagnosis of Primary Immunodeficiency, Hospital for Sick Children, Toronto, ON, Canada.
• ⁵ Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada.
• ⁶ Oracle Therapeutics (Canada) Inc, Toronto, ON, Canada.
• ⁷ Program in Cell Biology, Peter Gilgan Centre for Research and Learning, Hospital for Sick Children, Toronto, ON, Canada.
• ⁸ Department of Biochemistry, University of Toronto, Toronto, ON, Canada.
• ⁹ Department of Pediatrics, Faculty of Medicine, Ege University, Izmir, Turkey.
• ¹⁰ Dolunay Pediatric Clinic, Muratpasa, Antalya, Turkey.
• ¹¹ Department of Pediatric Gastroenterology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
• ¹² Vevo Therapeutics, San Francisco, CA.
• ¹³ The Centre for Applied Genomics, Hospital for Sick Children, Toronto, ON, Canada.